Sept 21 (Reuters) – Drug developer Iambic Therapeutics, backed by chip giant Nvidia and Qatar's sovereign wealth fund, filed for a US initial public offering on Monday, bolstering a busy slate of
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
VIDEO SHOWS: PRESS CONFERENCE WITH NETHERLANDS COACH XAVI HERNANDEZ AND CAPTAIN VIRGIL VAN DIJK SHOWS:…
WASHINGTON, Sept 23 (Reuters) - The National Highway Traffic Safety Administration said Wednesday it is…
By Pavel Polityuk KYIV, Sept 23 (Reuters) - Ukraine is exploring the use of Baltic…
WASHINGTON, Sept 23 (Reuters) - US business activity raced to a more than five-year high…
Sept 23 (Reuters) - Devon Energy Corporation: * ACTIVIST TOMS CAPITAL URGES DEVON TO EXPLORE…
VIDEO SHOWS: ARCHIVE FOOTAGE OF JAVIER AGUIRRE AS HE IS APPOINTED VALENCIA HEAD COACH SHOWS:…